Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study. Partelli S, Landoni L, Bartolomei M, Zerbi A, et al. Br J Surg 2024;111:znae178.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Partelli S, Landoni L, Bartolomei M, Zerbi A, et al. Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study. Br J Surg 2024;111:znae178.
PMID: 39213395